- $2.06m
- -$2.36m
- $1.93m
Brief: iSpecimen Q2 Net Income USD -2.11 Million
iSpecimen Inc expected to post a loss of 28 cents a share - Earnings Preview
iSpecimen Inc reports results for the quarter ended in March - Earnings Summary
Brief: iSpecimen Q1 Net Income USD -2.9 Million
iSpecimen Inc expected to post a loss of 27 cents a share - Earnings Preview
iSpecimen Inc reports results for the quarter ended in December - Earnings Summary
iSpecimen Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: iSpecimen Says Co May Offer To Sell Up To $1.5 Mln Of Shares
Brief: Ispecimen And Trimetis Life Sciences Announce Strategic Partnership To Help Transform Tissue-Based Research
iSpecimen Inc reports results for the quarter ended in September - Earnings Summary
Brief: iSpecimen Q3 Net Income USD -2.1 Million
iSpecimen Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Ispecimen Expects Q3 2023 Revenue To Be Between $2.6 To $2.8 Million
Brief: Ispecimen Inc Says Received A Deficiency Notice From Nasdaq Stock Market
Brief: iSpecimen To Cut About 20% Of Company's Total Workforce
Brief: iSun, Inc. Q2 Pretax Profit USD -2.499 Mln
iSpecimen Inc reports results for the quarter ended in June - Earnings Summary
iSpecimen Inc expected to post a loss of 30 cents a share - Earnings Preview
iSpecimen Inc reports results for the quarter ended in March - Earnings Summary